Co-treatment with Vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, suppresses radiotherapy-induced epithelial-to-mesenchymal transition, cancer cell stemness, and lung metastasis of breast cancer: ALK5 inhibitor suppressed radiation induced metastasis. Radiol Oncol [Internet]. 2022 Jul. 3 [cited 2026 Jul. 30];56(2):185-97. Available from: https://www.ojstest.computing.si/index.php/ro/article/view/3779